 Biotin
"Biotin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.
| Descriptor ID |
D001710
|
| MeSH Number(s) |
D03.383.129.308.080 D08.211.096
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biotin".
Below are MeSH descriptors whose meaning is more specific than "Biotin".
This graph shows the total number of publications written about "Biotin" by people in this website by year, and whether "Biotin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2005 | 0 | 2 | 2 | | 2006 | 0 | 1 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 1 | 0 | 1 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2014 | 0 | 2 | 2 | | 2015 | 0 | 2 | 2 | | 2016 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2019 | 2 | 0 | 2 | | 2022 | 0 | 2 | 2 | | 2025 | 2 | 0 | 2 | | 2026 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Biotin" by people in Profiles.
-
Sharp EE, Laforest L, Zhang Y, Xu KL, Cheng Z, Burdick JA, Gullbrand SE, Mauck RL. Streptavidin functionalized hyaluronic acid hydrogels for controlled and customizable drug delivery. Acta Biomater. 2026 Sep; 221:77-86.
-
Marschner S, Lee D, Rugg N, Brown B, Nestheide S, Wellington M, Kanias T, Tatari-Calderone Z, Bhujbal R, Finlon J, Rahman M, Cancelas JA. Multi-center development and validation of a standardized protocol for biotinylated red blood cell analysis. Transfusion. 2026 May; 66(5):923-932.
-
Van Keuren AM, Simoes CT, Tucker CL. Chemical Control of Protease Activity and Gene Expression Using a Biotin-Released Inhibitory Domain. ACS Synth Biol. 2025 08 15; 14(8):3065-3077.
-
Kanias T, George G, Sekiya J, Kelly K, Stanley C, Lee D, Finlon J, Rahman M, Gehris T, Bowen D, Barton M, Marschner S, Berg MP, Norris PJ. Optimization of biotinylation protocol for next generation studies of red blood cell survival after transfusion. Transfusion. 2025 Jul; 65(7):1360-1372.
-
Donnenberg AD, Kim-Shapiro DB, Kanias T, Moore LR, Kiss JE, Lee JS, Xiong Z, Wang L, Triulzi DJ, Gladwin MT. Optimizing interpretation of survival studies of fresh and aged transfused biotin-labeled RBCs. Transfusion. 2023 01; 63(1):35-46.
-
Ornoff DM, Balaban E, Major A, Berry A, Young E. The Missing Factor(s): Disseminated Amyloidosis Causing Coagulopathy Refractory to Plasma Transfusion. Am J Med. 2022 06; 135(6):721-723.
-
Pierce EC, Morin M, Little JC, Liu RB, Tannous J, Keller NP, Pogliano K, Wolfe BE, Sanchez LM, Dutton RJ. Bacterial-fungal interactions revealed by genome-wide analysis of bacterial mutant fitness. Nat Microbiol. 2021 01; 6(1):87-102.
-
Donnenberg AD, Kanias T, Triulzi DJ, Dennis CJ, Meyer EM, Gladwin M. Improved quantitative detection of biotin-labeled red blood cells by flow cytometry. Transfusion. 2019 08; 59(8):2691-2698.
-
Donnenberg AD, Kanias T, Triulzi DJ, Dennis CJ, Moore LR, Meyer EM, Sinchar D, Kiss JE, Normolle DP, Gladwin MT. Current good manufacturing practices-compliant manufacture and measurement of biotin-labeled red blood cells. Cytotherapy. 2019 07; 21(7):793-800.
-
Walth CB, Wessman LL, Wipf A, Carina A, Hordinsky MK, Farah RS. Response to: "Rethinking biotin therapy for hair, nail, and skin disorders". J Am Acad Dermatol. 2018 12; 79(6):e121-e124.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|